The Stem Cell Solutions for Intractable Diseases
  • 문의 및 상담
    031-707-6733

Home > R&D > Patents



Patents



  • 11.   Composition for preventing and treating stroke, comprising HLA homozygous induced pluripotent stem cell-derived neural precursor cells. Submitted to US (18/564,485) (2023.11.27)

  • 10.  Composition for screening treatment of early-onset Alzheimer's disease and method there of. Registered in Republic of Korea (102442670) (2022.09.06)

  • 09. Composition for preventing and treating stroke, comprising HLA homozygous induced pluripotent stem cell-derived neural precursor cells. Submitted (PCT/KR2022/007500) (2022.05.26)

  • 08. Huntington's disease cell model and Huntington's disease screening model using the same. Submitted (1020220002787, Republic of Korea) (2022.01.07)

  • 07.  Composition of preventing and treating the stroke comprising HLA-homozygous iPSC-derived neural precursor cells. Registered in Repulic of Korea (102329306) (2021.11.16)

  • 06. Huntington's disease treatment or prevention composition comprising human leukocyte antigen homozygous pluripotent stem cell-derived neural precursor cells. Registered in Republic of Korea (102329305) (2021.11.16)

  • 05. Induced pluripotent stem cells having presenilin protein mutants (E120K) derived from Alzheimer's disease patients. Registered in Republic or Korea (102203860) (2021.01.11)

  • 04. Induced pluripotent stem cells having amyloid precursor protein mutants (v715m) derived from Alzheimer's disease patients. Registered in Republic of Korea (102203861) (2021.01.11)

  • 03. Induced pluripotent stem cells of Alzheimer's disease patient with mutation (V715M) in amyloid precursor protein. Submitted (PCT/K2020/006056)

  • 02. Screening method for candidate drugs for Huntington's disease using induced pluripotent stem cells derived from Huntington's disease patients. Registered in Republic of Korea (101535253) (2015.07.02)

  • 01.  Pharmaceutical composition for the treatment of stroke comprising neural precursor cells derived from human induced pluripotent stem cells. Registered in Republic of Korea (101516352) (2015.04.23)